Yi-Xin Li1,2,3, Jin Wang4, Tian-Ze Sun2,3,5, Mo-Qi Lv1,2,3, Pan Ge1,2,3, Hao-Nan Li2,3,6, Dang-Xia Zhou1,2,3. 1. Department of Pathology, Medical School, Xi'an Jiaotong University, Xi'an, China. 2. Key Laboratory of Environment and Genes Related to Diseases, Ministry of Education, Xi'an, China. 3. Institute of Genetics and Developmental Biology, Xi'an, China. 4. Department of Obstetrics and Gynecology, Xi'an Angel Women's & Children's Hospital, Xi'an, China. 5. Department of Human Anatomy and Histology and Embryology, Medical School, Xi'an Jiaotong University, Xi'an, China. 6. Department of Pathogenic Biology and Immunology, Medical School, Xi'an Jiaotong University, Xi'an, China.
Abstract
AIM: To compare the pregnancy outcomes after day 5 blastocyst-stage embryo transfers (BET) versus day 6 BET following vitrified-warmed cycle and to evaluate whether the number of embryos transferred and the chromosomal status of embryo influence effect estimates. METHODS: A literature search (PubMed, Embase and MEDLINE) up to January 2019 was conducted to identify studies where women with day 6 BET were compared to women with day 5 BET. Only studies published in English language, on peer-reviewed journal were considered eligible. The following subgroup analyses were performed: (i) number of embryos transferred and (ii) chromosomal status of embryo. RESULTS: From a total of 1956 articles identified, 23 observational studies were included in the meta-analysis. We observed that day 6 BET were associated with lower implantation rate (risk ratio, RR: 1.17, 95% confidence interval, CI: 1.10-1.24), clinical pregnancy rate (RR: 1.17, 95% CI: 1.10-1.24), ongoing pregnancy rate (RR: 1.15, 95% CI: 1.07-1.24) and live birth rate (RR: 1.22, 95% CI: 1.11-1.33) than day 5 BET following vitrified-warmed cycle. The subgroup analysis found that the superiority of day 5 BET compared with day 6 BET is influenced by the number of embryos transferred and chromosomal status of embryos. CONCLUSION: Current evidence shows that day 5 BET is superior to day 6 BET following vitrified-warmed cycle in clinical practice. Due to the overall low quality of available evidence, more larger and well-conducted studies are needed to compare the pregnancy outcomes between day 5 and day 6 BET before drawing a clear conclusion.
AIM: To compare the pregnancy outcomes after day 5 blastocyst-stage embryo transfers (BET) versus day 6 BET following vitrified-warmed cycle and to evaluate whether the number of embryos transferred and the chromosomal status of embryo influence effect estimates. METHODS: A literature search (PubMed, Embase and MEDLINE) up to January 2019 was conducted to identify studies where women with day 6 BET were compared to women with day 5 BET. Only studies published in English language, on peer-reviewed journal were considered eligible. The following subgroup analyses were performed: (i) number of embryos transferred and (ii) chromosomal status of embryo. RESULTS: From a total of 1956 articles identified, 23 observational studies were included in the meta-analysis. We observed that day 6 BET were associated with lower implantation rate (risk ratio, RR: 1.17, 95% confidence interval, CI: 1.10-1.24), clinical pregnancy rate (RR: 1.17, 95% CI: 1.10-1.24), ongoing pregnancy rate (RR: 1.15, 95% CI: 1.07-1.24) and live birth rate (RR: 1.22, 95% CI: 1.11-1.33) than day 5 BET following vitrified-warmed cycle. The subgroup analysis found that the superiority of day 5 BET compared with day 6 BET is influenced by the number of embryos transferred and chromosomal status of embryos. CONCLUSION: Current evidence shows that day 5 BET is superior to day 6 BET following vitrified-warmed cycle in clinical practice. Due to the overall low quality of available evidence, more larger and well-conducted studies are needed to compare the pregnancy outcomes between day 5 and day 6 BET before drawing a clear conclusion.
Authors: G M Yerushalmi; T Shavit; S Avraham; M Youngster; A Kedem; I Gat; U S Dorofeyeva; S Mashiach; E Schiff; A Shulman; D S Seidman; A Wiser; E Maman; A Hourvitz; M Baum Journal: Sci Rep Date: 2021-05-21 Impact factor: 4.379
Authors: Andrea Abdala; Ibrahim Elkhatib; Aşina Bayram; Ana Arnanz; Ahmed El-Damen; Laura Melado; Barbara Lawrenz; Human M Fatemi; Neelke De Munck Journal: J Assist Reprod Genet Date: 2022-01-22 Impact factor: 3.412
Authors: Neelke De Munck; Aşina Bayram; Ibrahim Elkhatib; Andrea Abdala; Ahmed El-Damen; Ana Arnanz; Laura Melado; Barbara Lawrenz; Human Mousavi Fatemi Journal: PLoS One Date: 2022-04-25 Impact factor: 3.752